Last reviewed · How we verify
Caduet Pill
At a glance
| Generic name | Caduet Pill |
|---|---|
| Also known as | 5Mg-10Mg Tablet |
| Sponsor | The University of Texas Medical Branch, Galveston |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE) (PHASE4)
- Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)
- Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes (PHASE3)
- A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk (PHASE4)
- Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors (PHASE4)
- A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin (PHASE3)
- Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors
- Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Caduet Pill CI brief — competitive landscape report
- Caduet Pill updates RSS · CI watch RSS
- The University of Texas Medical Branch, Galveston portfolio CI